🔗 Share this article

A shadow market for unapproved weight-loss medications is being driven by TikTok fitness influencers and vendors on communication apps, according to recent findings.

Investigational Treatment Gaining Popularity Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its supposed fat-burning effects. Viewers are encouraged to contact these accounts directly for supplier links, while also receiving discount codes.

Active Commerce on Social Networks

Separately, a robust market exists on Telegram, where groups with numerous of members share “before and after” images, administration instructions and claims of rapid UK delivery. Vendors market the substance there before redirecting buyers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Early trials indicate it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Experts Express Worries

However, physicians and pharmacists have warned that the sale of what remains an unlicensed medication in the UK is a cause for concern and could lead to users administering products of unknown origin.

Several experts stated the demand for the experimental drug could be linked to the increasing cost of approved slimming treatments such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that must not be marketed or distributed for human use under the British medical regulations.

Several influencers attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate medicines, marketing, and consumer regulations, risking fines, legal action or imprisonment.

Platform Response and Content Removal

Based on TikTok, the platform has taken down violative material and banned related hashtags and search suggestions. The organization stated it was dedicated to keeping the service secure and allocating resources in enhancing enforcement strategies.

Digital Trading Operations

Research also discovered groups with up to nine thousand members marketing retatrutide using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately displays channels with numerous of users, populated with images of slimming results, glowing testimonials and step-by-step guides for preparing or administering at home.

Within moments of joining one group, a seller shared contact information, where most transactions take place. The vendor provided an instruction manual and promised shipping within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about body mass, medical conditions or previous experience.

Product Details and Pricing

Inside these communities, messages display dark colored parcels with Royal Mail stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at residence with purified liquid, or pre-filled injectors typically sold at £160 for 20 milligrams. When asked how long a injector should last, sellers give contradictory responses varying between a several days to “depends on your body”.

Platform Moderation and Security Measures

A representative for Telegram stated it regularly monitored dangerous material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting materials they can’t verify. Even if the science behind retatrutide is valid, these online versions may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit treatments are extremely risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.

Her team has previously seen individuals injured by self-injection from unverified suppliers. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from Eli Lilly said the substance was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a company experimental product not yet authorized … may expose users to potentially significant medical dangers”.